Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer
Yang Zhang(Albert Einstein College of Medicine), Amit Verma(M.J.P. Rohilkhand University), Kith Pradhan(Albert Einstein College of Medicine), Gaurav S. Choudhary(Albert Einstein College of Medicine), Srinivas Aluri(Albert Einstein College of Medicine), Milagros Carbajal(Albert Einstein College of Medicine), Daniel T. Starczynowski(Cincinnati Children's Hospital Medical Center), Aditi Shastri(The University of Texas MD Anderson Cancer Center), Anirban Maitra(NYU Langone Health), Tushar D. Bhagat(Albert Einstein College of Medicine), Shanisha Gordon-Mitchell(Albert Einstein College of Medicine), Beamon Agarwal(Providence College), Ulrich Steidl(Albert Einstein College of Medicine), Hui Zhang(Albert Einstein College of Medicine), Xiaoyi Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Huamin Wang(The University of Texas MD Anderson Cancer Center), Plabani Sahu(Albert Einstein College of Medicine), Srabani Sahu(Albert Einstein College of Medicine), Robert E. Martell(Curis (United States))
Cited by 1
Related Papers
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Recurrent <i>GNAS</i> Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
|Science Translational Medicine|2011|772